Brief: Index Pharmaceuticals Gets New Patent For Cobitolimod In South Korea

Flerie AB

20/10/2023 13:51

Oct 20 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * INDEX PHARMACEUTICALS HAS BEEN GRANTED A NEW PATENT FOR
COBITOLIMOD IN SOUTH KOREA
    * PATENT PROVIDES PROTECTION FOR USE OF COBITOLIMOD IN
TREATMENT
OF INFLAMMATORY BOWEL DISEASE.
    * PATENT WILL PROVIDE AN EXCLUSIVITY PERIOD UNTIL AUGUST
2040,
WITH POSSIBILITY OF UP TO 5 YEARS PATENT TERM EXTENSION

Source text for Eikon:  ID:nWkrbPbvSz 
Further company coverage:  INDEX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))